AHA Projects U.S. Womens Cardiovascular Disease Will Rise to 14.4% by 2050
An American Heart Association review published Feb. 25 in Circulation projects U.S. women with cardiovascular disease or stroke will rise from 10.7% in 2020 to 14.4% by 2050, driven by rising hypertension, diabetes and obesity.
Overview
The American Heart Association published a review in Circulation on Feb. 25 projecting that U.S. women with cardiovascular disease or stroke will increase from 10.7% in 2020 to 14.4% by 2050.
Researchers used national surveys from 2015 to 2020 and census population forecasts to extend historical trends of risk factors including blood pressure, diabetes and obesity into 2050.
Lead author Dr. Karen Joynt Maddox called the projection a "wake-up call" and AHA volunteer president Dr. Stacey Rosen described the findings as "a call to action," according to the statement.
By 2050 coronary disease is projected at 8.2% (6.9% in 2020), stroke 6.7% (4.1%), heart failure 3.6% (2.5%) and atrial fibrillation 2.3% (1.6%), the statement said.
The authors said diabetes could rise from 14.9% to 25.3% and obesity from 43.9% to 61.2%, urged prevention and early detection, and noted the analysis did not account for GLP-1 weight-loss drugs.
Analysis
Center-leaning sources frame the coverage as an urgent public-health warning by foregrounding AHA projections and rising percentages, prioritizing expert voices from the association and study authors, and closing with prevention guidance. Editorial framing emphasizes quantitative future increases and disparities while offering few methodological caveats, though direct exhortations appear primarily as source quotes.
FAQ
By 2050, coronary disease is projected at 8.2%, stroke at 6.7%, heart failure at 3.6%, and atrial fibrillation at 2.3%.
The primary drivers are rising hypertension (nearly 60% by 2050), diabetes (over 25%), and obesity (over 60%).
High blood pressure will increase most among Hispanic women (over 15%); obesity most among Asian women (nearly 26%); Black women will have the highest rates: over 70% high blood pressure, 71% obesity, nearly 28% diabetes.
One-third of women aged 22-44 will have cardiovascular disease (excluding high blood pressure); nearly 32% of girls aged 2-19 will be obese by 2050.
The analysis did not account for the impact of GLP-1 weight-loss drugs.
